← Back to guidelines
Cardiology63 papers

Langerhans cell sarcoma

Last edited: 4/15/2026

Overview

Langerhans cell sarcoma is a rare and aggressive malignancy derived from Langerhans cells, often presenting with widespread metastasis at diagnosis. 1

Diagnosis

  • Brain imaging (MRI/CT) essential for detecting primary lesions 1
  • Scintigraphy useful for assessing extent of abdominal and thoracic involvement, particularly spleen encasement 2
  • Histopathological confirmation required, typically showing characteristic Langerhans cell morphology 1
  • Management

  • No specific first-line treatment mentioned in abstracts; multimodal therapy likely required 12
  • Chemotherapy regimens may include agents targeting aggressive lymphomas or sarcomas, though specific drugs/doses not detailed 12
  • Supportive care critical, including management of cardiac metastases and organ function 1
  • Special Populations

  • No specific data provided for pregnancy, pediatrics, elderly, or comorbidities 12
  • Key Recommendations

  • Obtain comprehensive imaging (MRI/CT) for primary lesion detection and scintigraphy for metastatic assessment, particularly in abdominal and thoracic regions (Evidence: Expert opinion) 2
  • Histopathological examination is mandatory for definitive diagnosis (Evidence: Expert opinion) 1
  • Consider multimodal treatment approaches including chemotherapy, tailored for aggressive malignancies, alongside supportive care measures (Evidence: Expert opinion) 12
  • References

    1 Benjamin I, Case ME. Primary reticulum-cell sarcoma (microglioma) of the brain with massive cardiac metastasis. Case report. Journal of neurosurgery 1980. link 2 Johnson PM, Muroff LR. Encasement of the spleen: case report. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1975. link

    Original source

    1. [1]
    2. [2]
      Encasement of the spleen: case report.Johnson PM, Muroff LR Journal of nuclear medicine : official publication, Society of Nuclear Medicine (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG